Juan Pablo Ochoa

@jpocardio

Cardiologist. Clinical Director of Health in Code; researcher in CNIC and Puerta de Hierro Hospital (Inherited Cardiomyopathies). Owner and creator of Poolsito.

Madrid, Comunidad de Madrid Joined October 2010

333 Following 378 Followers 142 Posts

Latest posts 5

Pinned post

Juan Pablo Ochoa @jpocardio Aug 29, 2025

🚨 Live from #ESCCongress + now online in @CircAHA 🚨
ahajournals.org/eprint/IMVYICJ…
Honored to present our work on Intermediate-Effect Variants (IEVs) in HCM, selected for the Young Investigator Award. 🏆

60% of HCM cases G (-).
Maybe we’ve been looking in the wrong place… 👇🧵

Juan Pablo Ochoa @jpocardio Sep 19, 2024

Encantados y muy orgullosos de participar en algo tannimportante... ahora también en esta nueva función de "corresponsales". Los mantendremos informados!

Health in Code® Verified account @health_in_code Sep 18, 2024

En la redacción del nuevo documento participan nuestros compañeros cardiólogos @jpocardio y Soledad García-Hernández, así como nuestro consejero clínico ejecutivo: William McKenna, que compartirán su experiencia en el simposio 🤗
View quoted post on X

Juan Pablo Ochoa @jpocardio Jul 17, 2024

Proud of leading this beautiful project with @dr_pavia, with an important clinical message: genetic testing should be considered in all patients who received a PM at young age (<60 yo). Thanks to all the people involved in the project!

Pablo Garcia-Pavia @dr_pavia Jul 14, 2024

Five years ago I saw a 46 year-old 👧 at clinic who had a pacemaker (PM) implanted aged 43 due to complete AVB. No other 🫀 findings but her father and grand-father also received a PM at young age 🧐 (1/16)
View quoted post on X

Juan Pablo Ochoa @jpocardio Apr 25, 2024

Our work that firmly establishes that TBX20 truncating variants cause dilated cardiomyopathy (DCM) and left ventricular non-compaction (LVNC) is finally published at ahajournals.org/doi/10.1161/CI…. @roddywalsh @IacopoOlivotto @jpkaski @APLandstrom @cbezzina1 @dr_pavia @rbarvil

www.ahajournals.org Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction |... BACKGROUND: Less than 40% of patients with dilated cardiomyopathy (DCM) have a pathogenic/likely pathogenic genetic variant identified. TBX20 has been linked to congenital heart defects; although an...

Juan Pablo Ochoa @jpocardio Jan 3, 2024

📃📌Our paper “Intermediate-effect size p.Arg637Gln in FHOD3 increases risk of HCM and is associated with an aggressive phenotype in homozygous carriers” is available online jmg.bmj.com/content/early/… Here a brief thread of the main findings: